Keywords: ec, broadens, avastin, use, mcrc, indication, swiss

EC broadens Avastin use in mCRC indication

Article | 04 February 2008

Print This

Swiss drug major Roche says that the European Commission has approved the expanded use of the anti-angiogenic Avastin (bevacizumab) in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in